Suppr超能文献

非药物和药物干预措施减少或预防智力障碍人群行为挑战特征的系统评价和随机对照试验荟萃分析。

Non-pharmacological and pharmacological interventions for the reduction or prevention of topographies of behaviours that challenge in people with intellectual disabilities: a systematic review and meta-analysis of randomised controlled trials.

机构信息

School of Psychology, University of Birmingham, Birmingham, UK; Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK; Birmingham Community Healthcare NHS Foundation Trust, Birmingham, UK.

School of Psychology, University of Birmingham, Birmingham, UK.

出版信息

Lancet Psychiatry. 2023 Sep;10(9):682-692. doi: 10.1016/S2215-0366(23)00197-9.

Abstract

BACKGROUND

People with intellectual disability show a high prevalence of behaviours that challenge. Clinical guidelines recommend that such behaviour should first be treated with non-pharmacological interventions, but research suggests off-label pharmaceuticals are commonly used. We aimed to evaluate the efficacy of non-pharmacological and pharmacological interventions for topographies of behaviours that challenge drawn from randomised controlled trials (RCTs).

METHODS

In this systematic review and meta-analysis, we searched PsycINFO, MEDLINE, Embase, CINAHL, and CENTRAL databases for RCT studies assessing an intervention (pharmacological or non-pharmacological) for behaviours that challenge (self-injury behaviour, aggression, destruction of property, irritability, and a composite overall measure) in participants with intellectual disability. The primary aim was to assess the efficacy of non-pharmacological and pharmacological interventions on behaviours that challenge. Secondary aims were to evaluate how effects varied over time and whether intervention, methodological, and participant characteristics moderate efficacy. We extracted standard mean difference (SMD) effect sizes (Cohen's d) from eligible studies and meta-analysed the data using a series of random effects models and subgroup analyses. This study was registered with PROSPERO 2021, CRD4202124997.

FINDINGS

Of 11 912 reports identified, 82 studies were included. 42 (51%) studies assessed non-pharmacological interventions and 40 (49%) assessed pharmacological interventions. Across all studies, 4637 people with intellectual disability aged 1-84 years (mean age 17·2 years) were included. 2873 (68·2%) were male, 1339 (28·9%) were female, and for 425 (9·2%) individuals, data on gender were not available. Data on ethnicity were unavailable. Small intervention effects were found for overall behaviours that challenge at post-intervention (SMD -0·422, 95% CI -0·565 to -0·279), overall behaviours that challenge at follow-up (-0·324, -0·551 to -0·097), self-injury behaviour at post-intervention (-0·238, -0·453 to -0·023), aggression at post-intervention (-0·438, -0·566 to -0·309), and irritability at post-intervention (-0·255, -0·484 to -0·026). No significant differences between non-pharmacological and pharmacological interventions were found for any topography of behaviours that challenge (all p>0·05).

INTERPRETATION

A broad range of interventions for behaviours that challenge are efficacious with small effect sizes for people with intellectual disability. These findings highlight the importance of precision in the measurement of behaviours that challenge, and when operationalising intervention components and dosages.

FUNDING

Cerebra.

摘要

背景

智障人士表现出较高的挑战性行为发生率。临床指南建议首先应采用非药物干预措施来治疗这些行为,但研究表明,标签外药物通常被广泛使用。我们旨在评估非药物和药物干预措施对随机对照试验(RCT)中挑战性行为的疗效。

方法

在这项系统评价和荟萃分析中,我们在 PsycINFO、MEDLINE、Embase、CINAHL 和 CENTRAL 数据库中搜索了评估干预措施(药物或非药物)对智障参与者挑战性行为(自伤行为、攻击行为、破坏财产、易怒和综合整体测量)的 RCT 研究。主要目的是评估非药物和药物干预措施对挑战性行为的疗效。次要目的是评估疗效随时间的变化情况,以及干预、方法学和参与者特征是否会影响疗效。我们从合格研究中提取了标准均数差(SMD)效应大小(Cohen's d),并使用一系列随机效应模型和亚组分析对数据进行了荟萃分析。本研究已在 PROSPERO 2021、CRD4202124997 中注册。

结果

从 11 912 份报告中筛选出 82 项研究。42 项(51%)研究评估了非药物干预措施,40 项(49%)研究评估了药物干预措施。所有研究共纳入 11 岁至 84 岁(平均年龄 17.2 岁)的 4637 名智障人士。2873 人(68.2%)为男性,1339 人(28.9%)为女性,425 人(9.2%)的性别数据不详。种族数据不详。干预后整体挑战性行为(SMD -0.422,95%CI -0.565 至 -0.279)、干预后整体挑战性行为(SMD -0.324,95%CI -0.551 至 -0.097)、自伤行为(SMD -0.238,95%CI -0.453 至 -0.023)、攻击行为(SMD -0.438,95%CI -0.566 至 -0.309)和易怒行为(SMD -0.255,95%CI -0.484 至 -0.026)的干预效果较小。对于任何挑战性行为的治疗,非药物干预与药物干预之间均未发现有统计学意义的差异(均 P>0.05)。

结论

针对智障人士的挑战性行为,有多种干预措施都具有一定疗效,其疗效大小用效应量表示为小。这些发现强调了在测量挑战性行为、以及操作干预成分和剂量时精确性的重要性。

资助

Cerebra。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验